Compared to cases confirmed by human clinical testing, the air sampling used in the college dorms in the study had a success rate of 75%–100% in detecting infection by SARS-CoV-2.
Holidays set the table for the gathering of family and friends indoors. However, that could lead to trouble, as the Centers for Disease Control and Prevention (CDC) has pointed out during much of the COVID-19 pandemic.1 The horrific surge resulting from last year’s holidays taxed the US health care system and forced infection preventionists (IPs) and other health care professionals to work to the point of exhaustion.2,3
COVID-19 also exposed some serious systemic problems in the country’s health care system, most notably with nursing homes and other long-term care facilities (LTCFs).4 But COVID-19 also underscored the need for proper ventilation in buildings, not just hospitals and LTCFs but office buildings and especially schools.
A preprint study in the American Journal of Infection Control (AJIC) shows how easily COVID-19 can spread via ventilation units in college dormitories. Proper ventilation in schools is crucial.5 As Kevin Kavanagh, MD, a member of Infection Control Today®’s (ICT®’s) Editorial Advisory Board (EAB), told us in July6: “We need to change our infrastructure for schools with ventilation systems, increasing complete air exchanges.”
In the AJIC study, investigators with East Carolina University sampled the air in 2 multifloor dorms in search of SARS-CoV-2, detecting COVID-19 in multiple places and concluded that air sampling could be an effective way to monitor the safety of buildings.
The air samples were collected in the spring semester from January 19 to April 29, 2021, using the quantitative reverse transcription polymerase chain reaction (RT-qPCR) method. The 2 dorm buildings used in the study contain 225 rooms that include student dorms, offices, staff apartments, bathrooms, and storage space.
“We conducted the current study as a cleaner, easier, and safer alternative method to the wastewater track tracing method, and we have shown it is possible to detect viruses in HVAC air samples collected at 1 location from the dorm’s return air,” the study states. “It is possible that performing air sampling for SARS-CoV2 on each floor of a large building may yield greater sensitivity.”
In 2 large dorm rooms, investigators detected COVID-19 in 11 samples. “When compared with student nasal swab RT-qPCR testing, we detected SARS-CoV-2 in air samples when a PCR-positive COVID19 student was living on the same floor of the sampling location with a detection rate of 75%,” the study states.
Investigators argue that their study, which, to their knowledge, is the first to detect COVID-19 using PCR detection on air samples from HVAC systems, underscores the crucial role air monitoring can play in detecting pathogens in large buildings and “especially congregant living settings.” When it comes to stopping contamination, early intervention matters.
“Future building designs should include HVAC access for such sampling, and public health policies should consider implementation of HVAC surveillance testing either routinely or during times of contagion,” the study states. “Our data suggest air sampling at each floor would be beneficial and that more distant sampling is less sensitive.” Just how much their advice will be followed remains to be seen.
References:
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.